(FHLC) Fidelity MSCI Health Care - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3160926008 • Health
FHLC: Hospitals, Pharmaceuticals, Biotechnology, Medical, Devices, Equipment
The Fidelity MSCI Health Care Index ETF, listed on the NYSE ARCA under the ticker FHLC, is designed to track the performance of the health care sector within the U.S. equity market. To achieve this, the fund invests a minimum of 80% of its assets in securities that are components of its underlying index, the MSCI USA IMI Health Care 25/50 Index. This index is a broad representation of the health care sector, encompassing a wide range of companies involved in various aspects of health care, from pharmaceuticals and biotechnology to medical devices and health care services.
The MSCI USA IMI Health Care 25/50 Index is a market-capitalization-weighted index, meaning that the securities within the index are weighted according to their market capitalization, with larger companies having a greater influence on the index's performance. The fund may or may not hold all of the securities included in the MSCI USA IMI Health Care 25/50 Index, as its investment strategy allows for some flexibility in portfolio construction. It's worth noting that the fund is classified as non-diversified, which means it can invest a significant portion of its assets in a limited number of securities, potentially increasing its risk profile.
As an exchange-traded fund (ETF), the Fidelity MSCI Health Care Index ETF offers investors the opportunity to gain exposure to the health care sector in a single, tradeable security. The fund is part of the broader family of Fidelity ETFs, which are managed by Fidelity Investments, one of the largest financial services companies in the world. With its listing on the NYSE ARCA and its registration in the United States, the fund is subject to U.S. securities laws and regulations. The fund's ISIN, US3160926008, is a unique identifier used to facilitate international trading and clearing of the security.
Additional Sources for FHLC ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FHLC ETF Overview
Market Cap in USD | 2,622m |
Category | Health |
TER | 0.08% |
IPO / Inception | 2013-10-21 |
FHLC ETF Ratings
Growth 5y | 55.8% |
Fundamental | - |
Dividend | 47.1% |
Rel. Strength Industry | -85.4 |
Analysts | - |
Fair Price Momentum | 62.85 USD |
Fair Price DCF | - |
FHLC Dividends
Dividend Yield 12m | 1.46% |
Yield on Cost 5y | 2.14% |
Annual Growth 5y | 3.37% |
Payout Consistency | 86.0% |
FHLC Growth Ratios
Growth Correlation 3m | -79.6% |
Growth Correlation 12m | 33.9% |
Growth Correlation 5y | 81.5% |
CAGR 5y | 8.01% |
CAGR/Mean DD 5y | 1.54 |
Sharpe Ratio 12m | 0.02 |
Alpha | -17.73 |
Beta | 0.78 |
Volatility | 13.45% |
Current Volume | 135.4k |
Average Volume 20d | 158.9k |
As of January 23, 2025, the stock is trading at USD 67.79 with a total of 135,400 shares traded.
Over the past week, the price has changed by +1.57%, over one month by +2.62%, over three months by -4.89% and over the past year by +3.96%.
Partly, yes. Based on ValueRay Analyses, Fidelity MSCI Health Care (NYSE ARCA:FHLC) is currently (January 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.84 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FHLC as of January 2025 is 62.85. This means that FHLC is currently overvalued and has a potential downside of -7.29%.
Fidelity MSCI Health Care has no consensus analysts rating.
According to ValueRays Forecast Model, FHLC Fidelity MSCI Health Care will be worth about 69.4 in January 2026. The stock is currently trading at 67.79. This means that the stock has a potential upside of +2.35%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 69.4 | 2.3% |